Blockade of Central Cholinergic Receptors Impairs New Learning and Increases Proactive Interference in a Word Paired-Associate Memory Task

Behavioral Neuroscience

Volumn 118, Issue 1, 2004, Pages 223-236

  Atri, Alireza ^a   Norman, Kenneth A ^b   Nicolas, Marlene M ^a   Cramer, Steven C ^c,g   Hasselmo, Michael E ^a   Sherman, Seth ^a   Kirchhoff, Brenda A ^d   Greicius, Michael D ^e   Breiter, Hans C ^f   Stern, Chantal E ^a  

^a BOSTON UNIVERSITY   (United States)

^b PRINCETON UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e STANFORD UNIVERSITY   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLYCOPYRRONIUM BROMIDE; MUSCARINIC RECEPTOR; SCOPOLAMINE;

ADULT; AMNESIA; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HUMAN; HYPOTHESIS; LEARNING DISORDER; MALE; MEMORY CONSOLIDATION; MENTAL PERFORMANCE; PAIRED ASSOCIATE LEARNING; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREDICTION; PUPIL DISEASE; VERBAL MEMORY; WORD PAIRED ASSOCIATE MEMORY TASK; XEROSTOMIA;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CHOLINERGIC ANTAGONISTS; FEMALE; HUMANS; LEARNING; MALE; PROACTIVE INHIBITION; RECEPTORS, CHOLINERGIC; WORD ASSOCIATION TESTS;

EID: 10744229632     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.118.1.223     Document Type: Article

References (98)

1. Aggleton, J. P., & Brown, M. W. (1999). Episodic memory, amnesia and the hippocampal-anterior thalamic axis. Behavioral and Brain Sciences, 22, 425-444.
2. Aigner, T. G., Walker, D. L., & Mishkin, M. (1991). Comparison of the effects of scopolamine administered before and after acquisition in a test of visual recognition memory in monkeys. Behavioral and Neural Biology, 55, 61-67.
3. Ali-Melkkila, T., Kanto, J., & Iisalo, E. (1993). Pharmacokinetics and related pharmacodynamics of anticholinergic drugs. Acta Anaesthesiologica Scandinavica, 37(7), 633-642.
4. Baddeley, A. D., & Warrington, E. K. (1970). Amnesia and the distinction between long- and short-term memory. Journal of Verbal Learning and Verbal Behavior, 9, 176-189.
5. Bartus, R. T., & Johnson H. R. (1976). Short-term memory in the rhesus monkey: Disruption from the anti-cholinergic scopolamine. Pharmacology Biochemistry and Behavior, 5, 39-46.
6. Beatty W. W., Butters N., & Janowsky D. S. (1986). Patterns of memory failure after scopolamine treatment: Implications for cholinergic hypotheses of dementia. Behavioral and Neural Biology, 45, 196-211.
7. Bishop, K. I., Curran, H. V., & Lader, M. (1996). Do scopolamine and lorazepam have dissociable effects on human memory systems? A dose-response study with normal volunteers. Experimental and Clinical Psychopharmacology, 4, 292-299.
8. Blitzer, R. D., Gil, O., & Landau, E. M. (1990). Cholinergic stimulation enhances long term potentiation in the CA1 region of rat hippocampus. Neuroscience Letters, 119, 207-210.
9. Bolhuis, J. J., Strijkstra, A. M., & Kramers, R. J. (1988). Effects of scopolamine on performance of rats in a delayed-response radial maze task. Physiology & Behavior, 43, 403-409.
10. Brewer, J. B., Zhao, Z., Glover, G. H., & Gabrieli, J. D. E. (1998). Making memories: Brain activity that predicts whether visual experiences will be remembered or forgotten. Science, 281, 1185-1187.
11. Broks, P., Preston, G. C., Traub, M., Poppleton, P., Ward, C., & Stahl, S. M. (1988). Modelling dementia: Effects of scopolamine on memory and attention. Neuropsychologia, 26, 685-700.
12. Bullock R., & Cameron, A. (2002). Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: A case series. Current Medical Research Opinion, 18(5), 258-264.
13. Burgard, E. C., & Sarvey, J. M. (1990). Muscarinic receptor activation facilitates the induction of long-term potentiation (LTP) in the rat dentate gyrus. Neuroscience Letters, 116, 34-39.
14. Caine, E. D., Weingartner, H., Ludlow, C. L., Cudahy, E. A., & Wehry, S. (1981). Qualitative analysis of scopolamine-induced amnesia. Psychopharmacology, 74, 74-80.
15. Cermak, L. S., & Butters, N. (1972). The role of interference and encoding in the short-term memory deficits of Korsakoff patients. Neuropsychologia, 10, 89-95.
16. Corkin, S. (1984). Lasting consequences of bilateral medial temporal lobectomy: Clinical course and experimental findings in H. M. Seminars in Neurology, 4, 249-259.
17. Crow, T. J., & Grove-White, I. G. (1973). An analysis of the learning deficit following hyoscine administration to man. British Journal of Pharmacology, 49, 322-327.
18. Crowder, R. G. (1976). Principles of learning and memory. New York: Erlbaum.
19. Cummings, J. L. (2000, December 16). Cholinesterase inhibitors: Expanding applications. Lancet, 356, 2024-2025.
20. Curran, H. V., Pooviboonsuk, P., Dalton, J. A., & Lader, M. H. (1998). Differentiating the effects of centrally acting drugs on arousal and memory: An event-related potential study of scopolamine, lorazepam and diphenhydramine. Psychopharmacology (Berlin), 135, 27-36.
21. Damasio, A. R., Eslinger, P. J., Damasio, H., & Kassell, N. (1985). Amnesia following basal forebrain lesions. Archives of Neurology, 42, 263-271.
22. Davachi, L., Mitchell, J. P., & Wagner, A. D. (2003). Multiple routes to memory: Distinct medial temporal lobe processes build item and source memories. Proceedings of the National Academy of Sciences, USA, 100, 2157-2162.
23. DeRosa, E., & Hasselmo, M. E. (2000). Muscarinic cholinergic neuromodulation reduces proactive interference between stored odor memories during associative learning in rats. Behavioral Neuroscience, 114, 32-41.
24. Drachman, D. A. (1978). Central cholinergic system and memory. In M. A. Lipton, A. DiMascio & K. F. Killam (Eds.), Psychopharmacology: A generation of progress (pp. 651-662). New York: Raven Press.
25. Dudchenko, P., & Sarter, M. (1992). Behavioral microanalysis of spatial delayed alternation performance: Rehearsal through overt behavior, and effects of scopolamine and chlordiazepoxide. Psychopharmacology (Berlin), 107, 263-270.
26. Dundee, J. W., & Pandit, S. K. (1972). Anterograde amnesic effects of pethidine, hyoscine and diazepam in adults. British Journal of Pharmacology, 44, 140-144.
27. Dunnett, S. B., Wareham, A. T., & Torres, E. M. (1990). Cholinergic blockade in prefrontal cortex and hippocampus disrupts short-term memory in rats. NeuroReport, 1, 61-64.
28. Ebert, U., Siepmann, M., Oertel, R., Wesnes, K. A., & Kirch, W. (1998). Pharmacokinetics and pharmacodynamics of scopolamine after subcutaneous administration. Journal of Clinical Pharmacology, 38, 720-726.
29. Egorov, A. V., Hamam, B. N., Fransen, E., Hasselmo, M. E., & Alonso, A. A. (2002, November 14). Graded persistent activity in entorhinal cortex neurons. Nature, 420, 173-178.
30. Erkinjuntti, T., Kurz, A., Gauthier, S., Bullock, R., Lilienfeld, S., & Damaraju, C. V. (2002, April 13). Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: A randomised trial. Lancet, 359, 1283-1290.
31. Fransen, E., Alonso, A. A., & Hasselmo, M. E. (2002). Simulations of the role of the muscarinic-activated calcium-sensitive nonspecific cation current INCM in entorhinal neuronal activity during delayed matching tasks. Journal of Neuroscience, 22, 1081-1097.
32. Frith, C. D., Richardson, J. T. E., Samuel, M., Crow, T. J., & McKenna, P. J. (1984). The effects of intravenous diazepam and hyoscine upon human memory. Quarterly Journal of Experimental Psychology: Human Experimental Psychology, 36, A133-A144.
33. Ghoneim, M. M., & Mewaldt, S. P. (1975). Effects of diazepam and scopolamine on storage, retrieval and organization processes in memory. Psychopharmacologia, 44, 257-262.
34. Ghoneim, M. M., & Mewaldt, S. P. (1977). Studies on human memory: The interactions of diazepam, scopolamine and physostigmine. Psychopharmacology, 52, 1-6.
35. Graf, P. A., Squire, L. R., & Mandler, G. (1984). The information that amnesic patients do not forget. Journal of Experimental Psychology: Learning, Memory, and Cognition, 10, 164-178.
36. Grasby, P.M., Frith, C.D., Paulesu, E., Friston, K.J., Frackowiak, R.S., & Dolan, R.J. (1995). The effect of the muscarinic antagonist scopolamine on regional cerebral blood flow during the performance of a memory task. Experimental Brain Research, 104, 337-348.
37. Grober, E., Leipzig, R. M., Lipton, R. B., Wisniewski, W., Schroeder, M., Davies, P., Ritter, W., & Buschke, H. (1989). Does scopolamine directly impair memory? Journal of Cognitive Neuroscience, 1, 327-335.
38. Hasselmo, M. E. (1995). Neuromodulation and cortical function: Modeling the physiological basis of behavior. Behavioral Brain Research, 65, 1-27.
39. Hasselmo, M. E. (1999). Neuromodulation: Acetylcholine and consolidation. Trends in Cognitive Sciences, 3, 351-359.
40. Hasselmo, M. E., & Barkai, E. (1995). Cholinergic modulation of activity dependent synaptic plasticity in the piriform cortex: Brain slice physiology and computational modeling. Journal of Neuroscience, 15, 6592-6604.
41. Hasselmo, M. E., & Bower, J. M. (1992). Cholinergic suppression specific to intrinsic not afferent fiber synapses in rat piriform (olfactory) cortex. Journal of Neurophysiology, 67, 1222-1238.
42. Hasselmo, M. E., & Bower, J. M. (1993). Acetylcholine and memory. Trends in Neuroscience, 6, 218-222.
43. Hasselmo, M. E., & Linster, C. (1998). Neuromodulation and memory function. In P. S. Katz (Ed.), Beyond neurotransmission: The role of neuromodulation in information flow and neuronal circuit flexibility (pp. 318-348). Oxford, England: Oxford University Press.
44. Hasselmo, M. E., & Schnell, E. (1994). Laminar selectivity of the cholinergic suppression of synaptic transmission in rat hippocampal region CA1: Computational modeling and brain slice physiology. Journal of Neuroscience, 14, 3898-3914.
45. Hasselmo, M. E., Schnell, E., & Barkai, E. (1995). Learning and recall at excitatory recurrent synapses and cholinergic modulation in hippocampal region CA3. Journal of Neuroscience, 15, 5249-5262.
46. Hasselmo, M. E., & Wyble, B. P. (1997). Simulation of the effects of scopolamine on free recall and recognition in a network model of the hippocampus. Behavioural Brain Research, 89, 1-34.
47. Hasselmo, M. E., Wyble, B. P., & Wallenstein, G. V. (1996). Encoding and retrieval of episodic memories: Role of cholinergic and GABAergic modulation in the hippocampus. Hippocampus, 6, 693-708.
48. Herreras, O., Solis, J. M., Herranz, A. S., Martin del Rio, R., & Lerma, J. (1988). Sensory modulation of hippocampal transmission. II. Evidence for a cholinergic locus of inhibition in the Schaffer-CA1 synapse. Brain Research, 461, 303-313.
49. Herreras, O., Solis, J. M., Munoz, M. D., Martin del Rio, R. & Lerma, J. (1988). Sensory modulation of hippocampal transmission: I. Opposite effects on CA1 and dentate gyrus synapsis. Brain Research, 461, 290-302.
50. Hounsgaard, J. (1978). Presynaptic inhibitory action of acetylcholine in area CA1 of the hippocampus. Experimental Neurology, 62, 787-797.
51. Huerta, P. T., & Lisman, J. E. (1993, August 19). Heightened synaptic plasticity of hippocampal CA1 neurons during a cholinergically induced rhythmic state. Nature, 364, 723-725.
52. Kinsbourne, M., & Winocur, G. (1980). Response competition and interference effects in paired-associate learning by Korsakoff amnesics. Neuropsychologia, 18, 541-548.
53. Kirchhoff, B. A., Wagner, A. D., Maril, A., & Stern, C. E. (2000). Prefrontal-temporal circuitry for episodic encoding and subsequent memory. Journal of Neuroscience, 20, 6173-6180.
54. Klink, R., & Alonso, A. A. (1997). Muscarinic modulation of the oscillatory and repetitive firing properties of entorhinal cortex layer II neurons. Journal of Neurophysiology, 77, 1813-1828.
55. Korczyn, A. D. (2001). Dementia in Parkinson's disease. Journal of Neurology, 248(Suppl. 3), 1-4.
56. Linster, C., Wyble, B., & Hasselmo, M. E. (1999). Modulation of synaptic potentials in the piriform cortex by electrical stimulation of the horizontal limb of the diagonal band of Broca. Journal of Neurophysiology, 81, 2737-2742.
57. Mayes, A. R., Pickering, A., & Fairbaim, A. (1987). Amnesic sensitivity to proactive interference: Its relationship to priming and the causes of amnesia. Neuropsychologia, 25, 211-220.
58. McEvoy, G. K. (Ed.). (2002). AHFS drug information. Bethesda, MD: American Society of Health Systems.
59. McKeith, I., Del Ser, T., Spano, P., Emre, M., Wesnes, K., Anand, R., Cicin-Sain, A., Ferrara, R., & Spiegel, R. (2000, December 16). Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study. Lancet, 356, 2031-2036.
60. Mewaldt, S. P., & Ghoneim, M. M. (1979). The effect and interactions of scopolamine, physostigmine and methamphetamine on human memory. Pharmacology Biochemistry and Behavior, 10, 1205-1210.
61. M'Harzi, M., Palacios, A., Monmaur, P., Willig, F., Houcine, O., & Delacour, J. (1987). Effects of selective lesions of fimbria-fornix on learning set in the rat. Physiology & Behavior, 40, 181-188.
62. Mintzer, M. Z., & Griffiths, R. R. (2001). Acute dose-effects of scopolamine on false recognition. Psychopharmacology (Berlin), 153, 425-433.
63. Mintzer, M. Z., & Griffiths, R. R. (2003). Lorazepam and scopolamine: A single-dose comparison of effects on human memory and attentional processes. Experimental and Clinical Psychopharmacology, 11, 56-72.
64. Nissen, M. J., Knopman, D. S., & Schacter, D. L. (1987). Neurochemical dissociation of memory systems. Neurology, 37, 789-794.
65. Norman, K. A., & O'Reilly, R. C. (2003). Modeling hippocampal and neocortical contributions to recognition memory: A complementary learning systems approach. Psychological Review, 110, 611-646.
66. Numan, R., Feloney, M. P., Pham, K. H., & Tieber, L. M. (1995). Effects of medial septal lesions on an operant go/no-go delayed response alternation task in rats. Physiology & Behavior, 58. 1263-1271.
67. Numan, R., & Quaranta, J. R., Jr. (1990). Effects of medial septal lesions on operant delayed alternation in rats. Brain Research, 531, 232-241.
68. Pandit, S. K., & Dundee, J. W. (1970). Pre-operative amnesia. The incidence following the intramuscular injection of commonly used premedicants. Anaesthesia, 25(4), 493-449.
69. Patil, M. M., Linster, C., Lubenov, E., & Hasselmo, M. E. (1998). The cholinergic agonist carbachol enables associative long-term potentiation in piriform cortex slices. Journal of Neurophysiology, 80, 2467-2474.
70. Penetar, D. M., & McDonough, J. H., Jr. (1983). Effects of cholinergic drugs on delayed match-to-sample performance of rhesus monkeys. Pharmacology Biochemistry and Behavior, 19, 963-967.
71. Peterson, R. C. (1977). Scopolamine induced learning failures in man. Psychopharmacology, 52, 283-289.
72. Physician's drug reference. (2002). Montvale, NJ: Thomson Medical Economics.
73. Pompeu, F., & Growdon, J. H. (2002). Diagnosing dementia with Lewy bodies. Archives of Neurology, 59, 29-30.
74. Postle, B. R., Locascio, J. J., Corkin, S., & Growdon, J. H. (1997). The time course of spatial and object learning in Parkinson's disease. Neuropsychologia, 35, 1413-1422.
75. Postman, L., & Underwood, B. J. (1973). Critical issues in interference theory. Memory and Cognition, 1, 19-40.
76. Ragozzino, M. E., & Kesner, R. P. (1998). The effects of muscarinic cholinergic receptor blockade in the rat anterior cingulate and prelimbic/infralimbic cortices on spatial working memory. Neurobiology of Learning and Memory, 69, 241-257.
77. Robbins, T. W., Semple, J., Kumar, R., Truman, M. I., Shorter, J., Ferraro, A., Fox, B., McKay, G., & Matthews, K. (1997). Effects of scopolamine on delayed matching to sample and paired associates tests of visual memory and learning in human subjects: Comparison with diazepam and implications for dementia. Psychopharmacology, 134, 95-106.
78. Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., & Friedhoff, L. T. (1998). A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease: Donepezil Study Group. Neurology, 50, 136-145.
79. Rombouts, S. A., Barkhof, F., Van Meel, C. S., & Scheltens, P. (2002). Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 73, 665-671.
80. Rosenthal, R., Rosnow, R. L., & Rubin, D. B. (2000). Contrasts and effect sizes in behavioral research: A correlational approach. Cambridge, England: Cambridge University Press.
81. Safer, D. J., & Allen, R. P. (1971). The central effects of scopolamine in man. Biological Psychiatry, 3, 347-355.
82. Shannon, H. E., Bemis, K. G., Hendrix, J. C., & Ward, J. S. (1990). Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats. Journal of Pharmacology and Experimental Therapeutics, 255, 1071-1077.
83. Sherman, S. J., Atri, A., Hasselmo, M. E., Stern, C. E., & Howard, M. W. (2003). Scopolamine impairs human recognition memory: Data and modeling. Behavioral Neuroscience, 117, 526-539.
84. Sommer, B. R., Satlin, A., Friedman, L., & Cole, J. O. (1989). Glycopyrrolate versus atropine in post-ECT amnesia in the elderly. Journal of Geriatric Psychiatry and Neurology, 2, 18-21.
85. Sperling, R. A., Greve, D., Dale, A., Killiany, R., Holmes, J., Rosas, H. D., et al. (2002). Functional MRI detection of pharmacologically induced memory impairment. Proceedings of the National Academy of Sciences, USA, 99, 455-460.
86. Stern, C. E., Corkin, S., Gonzalez, R. G., Guimaraes, A. R., Baker, J. B., Jennings, P. J., et al. (1996). The hippocampal formation participates in novel picture encoding: Evidence from functional magnetic resonance imaging. Proceedings of the National Academy of Sciences, USA, 93, 8660-8665.
87. Storper, I. S., Spitzer, J. B., & Scanlan, M. (1998). Use of glycopyrrolate in the treatment of Meniere's disease. Laryngoseope, 108, 1442-1445.
88. Sutherland, R. J., Whishaw, I. Q. & Regehr, J. C. (1982). Cholinergic receptor blockade impairs spatial localization by use of distal cues in the rat. Journal of Comparative and Physiological Psychology, 96, 563-573.
89. Trinh, N. H., Hoblyn J., Mohanty S., & Yaffe, K. (2003). Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: A meta-analysis. Journal of the American Medical Association, 289, 210-216.
90. Troster, A. I., Beatty, W. W., Staton, R. D., & Rorabaugh, A. G. (1989). Effects of scopolamine on anterograde and remote memory in humans. Psychobiology, 17, 12-18.
91. Troyer, A. K., Winocur, G., Craik, F. I., & Moscovitch, M. (1999). Source memory and divided attention: Reciprocal costs to primary and secondary tasks. Neuropsychology, 13, 467-474.
92. Valentino, R. J., & Dingledine, R. (1981). Presynaptic inhibitory effect of acetylcholine in the hippocampus. Journal of Neuroscience, 1, 784-792.
93. Vilkki, J. (1985). Amnesic syndromes after surgery of anterior communicating artery aneurysms. Cortex, 21, 431-444.
94. Wagner, A. W., Schacter, D. L., Rotte, M., Koutstaal, W., Maril, A., Dale. A. M., et al. (1998, August 21). Building memories: Remembering and forgetting of verbal experiences as predicted by brain activity. Science, 281, 1188-1190.
95. Wesnes, K., Simpson, P., & Kidd, A. (1988). An investigation of the range of cognitive impairments induced by scopolamine 0.6 mg s. c. Human Psychopharmacology, 3, 27-81.
96. Whishaw, I. Q. (1985). Cholinergic receptor blockade in the rat impairs locale but not taxon strategies for place navigation in a swimming pool. Behavioral Neuroscience, 99, 979-1005.
97. Winson, J., & Abzug, C. (1977, June 10). Gating of neuronal transmission in the hippocampus: Efficacy of transmission varies with behavioral state. Science, 196, 1223-1225.
98. Zola-Morgan, S., Squire, L. R., & Amaral, D. G. (1986). Human amnesia and the medial temporal region: Enduring memory impairment following bilateral lesion limited to field CA1 of the hippocampus. Journal of Neuroscience, 6, 2950-2967.